Analysis of the Distribution and Drug Resistance of Pathogens in Patients with Urinary Tract Infection in the Eastern Chongming Area of Shanghai from 2018 to 2020
DOI: https://doi.org/10.2147/IDR.S384515
2022-11-02
Infection and Drug Resistance
Abstract:Jing Li, 1 Feifei Jiang, 2 An Xie, 3 Yufeng Jiang 1 1 Department of Urology, Chongming Branch of Shanghai Tenth People's Hospital, Shanghai, Tongji University School of Medicine, Shanghai, 202157, People's Republic of China; 2 Department of Clinical Laboratory, Chongming Branch of Shanghai Tenth People's Hospital, Shanghai, Tongji University School of Medicine, Shanghai, 202157, People's Republic of China; 3 Department of Nosocomial Infection Control, Chongming Branch of Shanghai Tenth People's Hospital, Shanghai, Tongji University School of Medicine, Shanghai, 202157, People's Republic of China Correspondence: Yufeng Jiang, Department of Urology, Chongming Branch of Shanghai Tenth People's Hospital, Shanghai, Tongji University School of Medicine, Shanghai, 202157, People's Republic of China, Tel +86 18101879807, Email Purpose: The aim of this study was to clarify the distribution and drug resistance of pathogens causing urinary tract infection (UTI) and to provide a scientific reference for the rational application of antibiotics. Patients and Methods: The results of bacterial identification and drug sensitivity analysis of midstream urine samples in our hospital from January 2018 to December 2020 were retrospectively analyzed. The data were analyzed using WHONET 5.6 and SPSS 26.0 (IBM) software. Results: In all, 1786 pathogens were isolated from 13,141 midstream urine culture samples. Of these, 1093 (61.2%) were gram-negative bacteria, mainly Escherichia coli [29.1%] and Klebsiella pneumoniae [14.3%]; 543 (30.4%) were gram-positive bacteria, mainly Enterococcus faecium [16.7%] and Enterococcus faecalis [8.4%]; and 150 (8.4%) were fungal isolates, with the most common being Candida albicans (3.7%). The resistance rates of E. coli to piperacillin/tazobactam (3.4% vs 10.0%, p < 0.05), ampicillin/sulbactam (43.0% vs 53.8%, p < 0.05), and ciprofloxacin (58.0% vs 72.9%, p < 0.05) increased significantly. K. pneumoniae was highly sensitive to ertapenem (100%). Two Enterococcus spp were highly sensitive to tigecycline (100%), and a small number of norvancomycin-resistant strains were found. The drug resistance rate of E. faecium to quinupristin was 6.7%. The drug resistance rates of E. faecalis to furantoin and ampicillin were 4.0% and 4.7%, respectively. Conclusion: The pathogens that cause UTIs in patients are diverse, with the most common being E. coli . The isolated pathogens exhibited different resistance patterns. Antibiotics should be rationally selected based on the resistance patterns of the pathogens. Keywords: urinary tract infections, midstream urine culture, pathogenic bacteria distribution, antimicrobial agent, antibiotic resistance Urinary tract infections (UTIs) are common infections that are primarily caused by bacteria and typically require antibiotic treatment. 1 However, delays in laboratory diagnosis of the causative pathogens often lead clinicians to initiate empiric antibiotic therapy. In the past 80 years, empirical use, overuse, and misuse of antimicrobial agents have been linked to outbreaks of antimicrobial resistance. 2 In recent years, superbugs and multidrug-resistant bacteria have rapidly emerged worldwide and are spreading in every country at a faster rate than expected, which poses a significant threat to human health. 3 If not tackled promptly and effectively, the problem of antimicrobial resistance can potentially cause millions of preventable deaths and hundreds of billions of pounds in economic costs each year. 4 Considerable research and analysis have been carried out worldwide regarding antibiotic resistance in bacteria. In The Lancet, Cassini et al 5 emphasized that the adverse impact of drug-resistant bacterial infections remains one of the greatest challenges to global public health. The analysis of the distribution and drug resistance of UTI pathogens is beneficial to the rational use of antibiotics. However, the distribution and drug resistance are regional and temporal, and the experience of different countries and regions is only for reference. 6 Recent studies have indicated that the prevalence of antibiotic resistance in gram-negative uropathogens varies widely across the world. For example, Klebsiella pneumoniae had extensive antibiotic resistance mechanisms, and until 2005, few carbapenem-resistant Klebsiella strains were reported in Europe, but between 2005 and 2015, it appeared in multiple countries at a rate of 40%–60%. 7 Even within the same country, the resistance rates of uropathogenic <e -Abstract Truncated-
pharmacology & pharmacy,infectious diseases